MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-HR-07-0000766
Paksons Pharmaceuticals Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹3.58 Cr
▼ 30% YoY
Net profit · FY 2025
₹12.01 Lakh
Net margin 3.4%
EBITDA · FY 2025
₹28.13 Lakh
EBITDA margin 7.9%
Authorised capital
₹35 Lakh
Registered with MCA
Paid-up capital
₹9.62 Lakh
Issued & subscribed
Open charges
₹1.66 Cr
Secured borrowings
Company age
28 yrs
Est. 1998
Employees · EPFO
8
Provident fund records
About Paksons Pharmaceuticals Private Limited
Data last updated:
Paksons Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 February 1998 and has been in existence for over 28 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1998PTC092394. Its GSTIN is 06AACCP0914F1ZW (Haryana).
The company has an authorised share capital of ₹35 Lakh and a paid-up capital of ₹9.62 Lakh. It is led by directors Sushil Kumar Aggarwal and Sumit Aggarwal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 2 – 215 Agarsain Commercialcomplex L S C – 7 Sector – 9 Rohini, Delhi, India – 110085.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.58 Cr, a decline of 30% compared to the previous year. For the same year it recorded a net profit of ₹12.01 Lakh (net margin 3.4%) and EBITDA of ₹28.13 Lakh (EBITDA margin 7.9%). Revenue has declined at a compounded annual rate (CAGR) of 19% over three years and 5% over five years.
The company has about 8 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Paksons Pharmaceuticals. As per MCA filings, the company has open charges of ₹1.66 Cr on record. Court records list 35 cases involving the company, including 2 filed by the company and 33 filed against it; 1 case is pending.
Paksons Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-07-0000766). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website paksonspharmaceuticals.com.
Company details
CIN U74899DL1998PTC092394
Registration Number 092394
Incorporation Date 23 February 1998
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-HR-07-0000766
Recognitions & Rankings of Paksons Pharmaceuticals
Contact details
Paksons Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its website is paksonspharmaceuticals.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address2 – 215 Agarsain Commercialcomplex L S C – 7 Sector – 9 Rohini, Delhi, India – 110085
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Paksons Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Paksons Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Paksons Pharmaceuticals operates one associated brand: PAKSONS PHARMACEUTICALS. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical products are manufactured and sold by the company in India. | paksonspharmaceuticals.com |
Business activity
The main business activity of Paksons Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Paksons Pharmaceuticals Private Limited, buy the company report.
Financials of Paksons Pharmaceuticals Private Limited
FY 2025 filings availablePaksons Pharmaceuticals Private Limited reported revenue of ₹3.58 Cr (down 30% YoY) for FY 2025.
Revenue · FY 2025
₹3.58 Cr ▼ 30%
Net profit · FY 2025
₹12.01 Lakh margin 3.4%
EBITDA · FY 2025
₹28.13 Lakh margin 7.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 30%
3 years · compounded
▼ 19%
5 years · compounded
▼ 5%
EBITDA CAGR growth
1 year
▼ 46%
3 years · compounded
▼ 21%
5 years · compounded
▲ 4%
Revenue has declined at a compounded annual rate (CAGR) of 5% over five years, including a 30% fall in the latest year. EBITDA fell 46% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹28.13 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹12.01 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.9% | ||||
| Net Profit Margin | 3.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Paksons Pharmaceuticals Private Limited, buy the company report.
Board of directors of Paksons Pharmaceuticals Private Limited
Paksons Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sushil Kumar Aggarwal Also directs: Biomaxgen Pharmaa LLP, Tescos Life Care Private Limited | Director | 23 Feb 1998 | 28 Years 8 Months | Current |
| Sumit Aggarwal | Director | 15 Nov 2002 | 23 Years 11 Months | Current |
Auditor
Paksons Pharmaceuticals Private Limited is audited by ARPNAGUPTA for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ARPNAGUPTA | FY 2024 | 527250 |
Shareholding
The shareholding of Paksons Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Paksons Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1.66 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 Sep 2022 | 100621675 | Others | ₹9.4 Lakh | Open | |
| 29 Aug 2022 | 100621230 | Others | ₹15 Lakh | Open | |
| 07 Feb 2017 | 100083394 | Others | ₹6 Lakh | Open | |
| 11 Jan 2017 | 100084950 | Others | ₹2.65 Lakh | Open | |
| 02 Feb 2016 | 100031677 | Vijaya Bank | ₹50 Lakh | Open |
To see the full charge records of Paksons Pharmaceuticals Private Limited, buy the company report.
Total charge records: 8 View all charges
Legal cases
Paksons Pharmaceuticals Private Limited has 35 court cases on record: 2 filed by Paksons Pharmaceuticals, 33 filed against it. 1 case is pending and 34 are disposed.
Total cases
35
Filed by the company
2
Filed against the company
33
Pending
1
Disposed
34
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 31 | 31 | 1 |
| High courts | 4 | 2 | 0 |
Cases on record (5 of 35)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Rangareddy, Telangana | Criminal complaint | Filed against the company by an individual | Pending |
| District court, North East, Delhi | Civil suit | Filed against the company by State | Disposed |
| District court, North, Delhi | Civil suit | Filed against the company by State | Disposed |
| District court, North West, Delhi | Civil suit | Filed against the company by State | Disposed |
| District court, South West, Delhi | Civil suit | Filed against the company by State | Disposed |
To see the full case history of Paksons Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Paksons Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Paksons Pharmaceuticals Private Limited has a workforce of 8 employees on its EPFO records as of Apr 09, 2024, across 1 active EPFO establishment.
Employee count
8
Active EPFO establishments
1
Employee growth
-11.11%
GST
Paksons Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AACCP0914F1ZW | Haryana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Paksons Pharmaceuticals Private Limited, buy the company report.
Recent activity
Paksons Pharmaceuticals Private Limited has 2 board changes on record since 1998: 2 appointments. The latest: Sumit Aggarwal was appointed as Director on 15 Nov 2002.
AGM
Paksons Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Paksons Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge with Others amounted to Rs. 9.40 Lakh with Charge ID 100621675 was registered on 23 Sep 2022.
Charges
A charge with Others amounted to Rs. 15.00 Lakh with Charge ID 100621230 was registered on 29 Aug 2022.
Charges
A charge with Vijaya Bank of Rs. 50.00 Lakh registered on 02 Feb 2016 with Charge ID 100031677 was modified on 17 Dec 2018.
Charges
A charge with Others of Rs. 30.00 Lakh registered on 27 Aug 2015 with Charge ID 10597261 was modified on 27 Feb 2017.
Charges
A charge with Others amounted to Rs. 6.00 Lakh with Charge ID 100083394 was registered on 07 Feb 2017.
Charges
A charge with Others amounted to Rs. 2.65 Lakh with Charge ID 100084950 was registered on 11 Jan 2017.
Charges
A charge with Vijaya Bank amounted to Rs. 50.00 Lakh with Charge ID 100031677 was registered on 02 Feb 2016.
Charges
A charge with Others amounted to Rs. 30.00 Lakh with Charge ID 10597261 was registered on 27 Aug 2015.
Charges
A charge with Vijaya Bank of Rs. 40.00 Lakh registered on 11 Jul 1999 with Charge ID 90035281 was modified on 21 May 2014.
Charges
A charge with Vijaya Bank amounted to Rs. 13.00 Lakh with Charge ID 10085899 was registered on 24 Dec 2007.
4 earlier events are in the company report.
Frequently asked questions
Paksons Pharmaceuticals is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 23 February 1998 (28+ years old) and is registered under CIN U74899DL1998PTC092394.
Paksons Pharmaceuticals has 2 current directors:
- Sushil Kumar Aggarwal - Director
- Sumit Aggarwal - Director
The latest financial statements of Paksons Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Paksons Pharmaceuticals is 06AACCP0914F1ZW, registered in Haryana.
The CIN (Corporate Identification Number) of Paksons Pharmaceuticals is U74899DL1998PTC092394. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Paksons Pharmaceuticals has 35 court cases on record: 2 filed by the company and 33 filed against it. 1 is pending. Most are in the district courts.
Paksons Pharmaceuticals was incorporated on 23 February 1998, making it 28+ years old. It is registered with the Registrar of Companies, Delhi.
Sumit Aggarwal was appointed as Director on 15 Nov 2002. Sushil Kumar Aggarwal was appointed as Director on 23 Feb 1998.
Yes, Paksons Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-HR-07-0000766).
Paksons Pharmaceuticals can be reached through the website paksonspharmaceuticals.com. Its registered office is in Delhi, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages